Loading company…
Mirror Biologics develops immunotherapy products and manufacturing programs for cancer and infectious diseases.
Founded in 2019 and based in Wesley Chapel, Mirror Biologics develops immunotherapy products, including its lead product AlloStim®, and the Mirror Effect® platform for cancers, infectious diseases, and immune system conditions. The company operates in the US, Israel, and Thailand. In October 2022, it raised USD 20 million in venture funding from Bradbury Asset Management (Hong Kong), Limited Fund. It planned to expand clinical programs and manufacturing capacity and advance its development programs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in